ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Most Comprehensive Centers Getting Core Grants Renewed

July 27, 1990

New Genetic Test Approved For Breast Cancer Patients

July 25, 2008

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005

NCAB Shaping Up, But Reverts to Nonsense When Discussing “Role Of The Board”

March 11, 1983

American cancer Society Funds 84 Research Grants. NCI, NIGMS To Support Synchrotron Beamlines.

November 16, 2001